DeepMed Research

UNIVERSITY OF ARIZONA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-01-01

Employees: 10K

Market Cap: -

Website: http://www.arizona.edu

Clinical Trials

Evaluation of Fluid Infusion With LifeFlow for Patients With Suspected Septic Shock

Not Applicable

Withdrawn

Conditions: Sepsis
Volume Assessment

Interventions: Device: Life Flow

First Posted Date: 2018-09-17

Last Posted Date: 2019-07-15

Lead Sponsor: University of Arizona

Registration Number: NCT03673891

Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

Not Applicable

Completed

Conditions: Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)
Breast Cancer

Interventions: Diagnostic Test: Initial blood draw
Diagnostic Test: Initial SWE ultrasound
Diagnostic Test: Blood draw at three months
Diagnostic Test: Blood draw at six months
Diagnostic Test: SWE ultrasound at six months

First Posted Date: 2018-09-11

Last Posted Date: 2023-08-24

Lead Sponsor: University of Arizona

Target Recruit Count: 28

Registration Number: NCT03665077

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets

Early Phase 1

Completed

Conditions: Bone Metastases
Breast Cancer
Pain

Interventions: Drug: Syndros

First Posted Date: 2018-09-07

Last Posted Date: 2021-04-29

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT03661892

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Cardioprotective Effects of Freeze Dried Grape Powder on Blood Pressure and Plasma Lipids/Lipoproteins

Not Applicable

Terminated

Conditions: Cardiovascular Risk Factor

Interventions: Dietary Supplement: Grape Powder
Dietary Supplement: Placebo Powder

First Posted Date: 2018-09-06

Last Posted Date: 2024-02-15

Lead Sponsor: University of Arizona

Target Recruit Count: 16

Registration Number: NCT03659695

Locations: 🇺🇸
University of Arizona Agricultural Center, Tucson, Arizona, United States

Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

Phase 3

Completed

Conditions: Iron Deficiency Anemia of Pregnancy

Interventions: Dietary Supplement: Ferrous sulfate 325mg
Drug: Ferumoxytol

First Posted Date: 2018-09-05

Last Posted Date: 2022-09-07

Lead Sponsor: University of Arizona

Target Recruit Count: 124

Registration Number: NCT03657433

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Probing Cortical Excitability and Cognitive Function With TMS

Not Applicable

Conditions: Cognitive Dysfunction

Interventions: Device: Transcranial Magnetic Stimulation (TMS)

First Posted Date: 2018-08-29

Last Posted Date: 2021-04-30

Lead Sponsor: University of Arizona

Target Recruit Count: 40

Registration Number: NCT03652012

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Post Hysterectomy Benefits of Retained Cystoscopy Fluid

Not Applicable

Completed

Conditions: Urinary Retention

Interventions: Procedure: Emptied fluid
Procedure: Retained fluid

First Posted Date: 2018-08-24

Last Posted Date: 2020-01-29

Lead Sponsor: University of Arizona

Target Recruit Count: 120

Registration Number: NCT03646136

Locations: 🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States

Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment

Not Applicable

Terminated

Conditions: Coccidioidomycosis
Valley Fever

Interventions: Other: Cholesterol-containing moisturizers

First Posted Date: 2018-08-07

Last Posted Date: 2021-06-04

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT03618992

Locations: 🇺🇸
Valley Fever Center for Excellence, Tucson, Arizona, United States
🇺🇸
University of Arizona - Banner University Medicine Dermatology, Tucson, Arizona, United States

Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer

Phase 2

Terminated

Conditions: Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7
Stage II Oropharyngeal Squamous Cell Carcinoma AJCC V7
CDKN2A-p16 Positive
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7

Interventions: Drug: Alpelisib
Other: Laboratory Biomarker Analysis
Other: Pharmacodynamic Study
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2018-07-26

Last Posted Date: 2024-04-17

Lead Sponsor: University of Arizona

Target Recruit Count: 9

Registration Number: NCT03601507

Locations: 🇺🇸
The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States

Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy

Phase 2

Terminated

Conditions: Head and Neck Carcinoma

Interventions: Drug: Chlorine Dioxide Sterilization
Other: Laboratory Biomarker Analysis
Other: Placebo

First Posted Date: 2018-07-26

Last Posted Date: 2024-03-20

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT03602066

Locations: 🇺🇸
The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy